Protagonist Therapeutics (PTGX) Earnings Date & Reports

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

PTGX is expected to report earnings to rise 211.26% to -59 cents per share on July 31

Protagonist Therapeutics PTGX Stock Earnings Reports

Q2'25

Est.

$-0.59

Q1'25

Missed

by $0.13

Q4'24

Beat

by $1.79

Q3'24

Beat

by $0.04

Q2'24

Beat

by $0.10

The last earnings report on May 29 showed earnings per share of -18 cents, missing the estimate of -6 cents. With 947.37K shares outstanding, the current market capitalization sits at 3.34B.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+30%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

PTGX